Endoscopic Surgery for Adrenal Tumors: Not Quicker, Not Cheaper, but Better for Patients

Publication
Article
OncologyONCOLOGY Vol 12 No 5
Volume 12
Issue 5

Dr. Charles H. Mayo performed one of the first successful operations to remove a tumor from the adrenal glands in 1927. After 187 days in the hospital, the patient recovered completely.

Dr. Charles H. Mayo performed one of the first successful operations to remove a tumor from the adrenal glands in 1927. After 187 days in the hospital, the patient recovered completely.

Today, this relatively rare surgery is commonly done with endoscopes, tiny tubes that enable the surgeon to view and work inside the body through small incisions.In a recent publication of Surgery, Mayo Clinic surgeons compare the results of adrenal surgery done endoscopically with the traditional “open” way on a matched set of 100 patients. Their findings mimic those of other comparison studies, showing that minimal access surgery results in shorter hospitalizations, fewer complications, and quicker return to normal but slightly higher operating room costs. Specific findings are on Table 1.

Dr. Geoffrey Thompson, the author of the report, says that minimal access surgery “is not necessarily easier, quicker, cheaper or safer. But it does have benefits for the patient and for society that are making it the procedure of choice for many purposes, including removal of adrenal tumors.”

Recent Videos
Findings from the phase 2b ReNeu trial show significant pain relief with mirdametinib in adult and pediatric patients with NF1-PN.
Findings from the CodeBreak 300 study have cemented sotorasib/panitumumab as a third-line treatment option for KRAS G12C-mutated colorectal cancer.
The dispersible tablet formulation of mirdametinib may offer convenience to patients with NF1-PN and difficulty with swallowing pills.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content